Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 13:00:05 UTC, with 10 holding rows worth $125,163,396.

Accession
0001193125-26-462150
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 10 entries on the cover page, a total value of $125,163,396 stated on the cover page (in dollars after the unit check, H1), rows summing to $125,163,395 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NUVATION BIO INC COM CL A67080N101Stock7,151,031$40,045,774dollars as filed
BICARA THERAPEUTICS INC055477103COM1,759,912$32,751,962dollars as filed
BETA BIONICS INC08659B102COMMON STOCK962,010$18,258,950dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW3,289,661$13,487,610dollars as filed
KESTRA MED TECHNOLOGIES LTDG52441105SHS362,394$10,252,126dollars as filed
IMMUNIC INC4525EP200COM NEW430,180$4,000,674dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$2,463,750dollars as filed
IMAGENEBIO INC45175G207CMN455,361$2,085,553dollars as filed
ENGENE HOLDINGS INC29286M105COM876,357$1,752,714dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK2,893$64,282dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-462150this filing2026-11-16